PREVENTION OF EARLY POSTOPERATIVE COMPLICATIONS OF INTESTINAL SURGERY USING IMMUNOMODULATING THERAPY
Summary. The aim of the study is to develop a method of immunocorrection, which improves the results of treatment of patients with developed peritonitis against the background of the small intestine anastomosis leakege by stopping the cascade of SIRS and MOF.
Materials and methods. The work was clinical in nature, was performed in the clinic of the SI «ZIGUS NAMSU» in the period from 2016 to 2019. We examined 58 patients with various diseases of the abdominal organs complicated by peritonitis, in which sections of the small intestine were resected. The Comparison Group included patients who received traditional therapy, patients of the Main Group, the complex of drug therapy included recombinant interleukin-2, galavit and α-lipoic acid. The results of surgical treatment were evaluated according to the classification of D. Dindo, N. Demartinesta, P.-A. Clavien (2004). Statistical analysis was removed from the Statistica 6.0 software (StatSoft, Inc. 2001) and SPSS 7.5 on Apple PC.
Results and Discussion. Thus, the results of the use of a comprehensive immunomodulation scheme using IL-2, galavit and α-lipoic acid in the complex treatment of patients with widespread peritonitis against the background of intestinal anastomosis failure suggest that the developed scheme has a targeted immunoregulatory effect and prevents the excess production of inflammatory mediators in the early postoperative the period of the disease, helps to eliminate the cytokine imbalance and prevents the development of secondary immune deficiency. A comparative analysis of the incidence of complications revealed that in patients of the Main Group the average number of complications per patient was 0.53, while in the Comparison Group this indicator was 1.36.
Conclusions. The use of a combination of IL-2, galavit and α-lipoic acid in the complex of treatment of common peritonitis helps to reduce the level of systemic and local postoperative complications, as well as the level of postoperative mortality.
2. Кryvoruchko ІА, Boyko VV, Іvanova YV, Аndreieshchev SА. Sepsis-3: renewed determinations, potential problems and further practical foot steps. Klinicheskaia Khirurgiia. 2019;86(6):60-72. https://doi.org/10.26779/2522-1396.2019.06.60
3. Berlot G, Tomasini A, Viviani M. SIRS, Sepsis, and MODS. Infection Control in the Intensive Care Unit:537–47. https://doi.org/10.1007/88-470-0361-X_24
4. Orlov Y.I. Intravascular Hemolysis of Red Blood Cells in the Development of Organ Dysfunctions in Critical Conditions. General Reanimatology. 2008;4(2):88. (In Russ.) https://doi.org/10.15360/1813-9779-2008-2-88
5. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surgical clinics. 2000;Vol.80;Iss.3:885–94. https://doi.org/10.1016/S0039-6109(05)70102-X
6. Karandin VI, Rozhkov AG, Tsarev MI, Nagayev RM, Tikhonov PA. Evaluation of the Severity of Surgical Endotoxicosis. General Reanimatology. 2009;5(5):49. (In Russ.) https://doi.org/10.15360/1813-9779-2009-5-49
7. Skripko VD, Kovalenko AL, Zaplutanov VA. Korrekcija narushenij mikrojelementnogo gomeostaza i okislitelnogo stressa u pacientov s ostroj tonkokishechnoj neprohodimostiu. Hirurgija. Zhurnal im. N.I. Pirogova. 2017;6: 55-59. https://doi.org/10.17116/hirurgia2017655-59
8. Green J, Doughty L, Kaplan SS, Sasser H, Carcillo JA. The Tissue Factor and Plasminogen Activator Inhibitor Type-1 Response in Pediatric Sepsis-induced Multiple Organ Failure. Thromb Haemost. 2002;87(02): 218–23. https://doi.org/10.1055/s-0037-1612976
9. Sartelli M, Abu-Zidan FM, Labricciosa FM, et al. Physiological parameters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study. World J Emerg Surg. 2019;14:34. https://doi.org/10.1186/s13017-019-0253-2
10. Glukhov AI, Gryzunova GK, Usai LI, Aleynikova TL, Chernikova NV, Burt AY. The Role of Apoptosis in the Pathogenic Mechanism of Critical States (Review). General Reanimatology. 2019;15(2):79-98. (In Russ.) https://doi.org/10.15360/1813-9779-2019-2-79-98
11. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood;2003;101(10):3765–77. https://doi.org/10.1182/blood-2002-06-1887
12. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality. J Immunol. 2006; 177: 1967-74. doi: 10.4049/jimmunol.177.3.1967